Biosimilars

Will a pilot project to prequalify “generic” biologics improve safe access to medicines?

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

Surface plasmon resonance has become a go-to tool for biotherapeutic characterization.

President Trump has the opportunity to get healthcare moving by boosting biogeneric use.

Sitting Down With... Fiona Greer, a biosimilar guru from SGS.

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?

We investigate the advantages and limitations of microcalorimetry in biopharma.

How inspiration from the airline industry could help improve the biosimilars industry.

Biosimilar drugmakers should remember that the best cake is one that doesn't have to be shared.

Our infographic shows how much can be saved with generic drugs